New initiative speeds tuberculosis drug development: novel drug regimens become possible in years, not decades.
Spigelman
Mel
M
Woosley
Raymond
R
Gheuens
Jan
J
D000995:Antitubercular Agents / Q000627:therapeutic use*; D004196:Disease Outbreaks / Q000517:prevention & control; D015195:Drug Design; D004345:Drug Industry / Q000639:trends*; D014943:Global Health; D006801:Humans; D014376:Tuberculosis / Q000188:drug therapy* / Q000453:epidemiology
D000995:Antitubercular Agents